Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24213868 | 0.82 | KDM4E (1.00) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL26031926 | 0.80 | KDM4E (0.69) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL5366429 | 0.79 | KDM4E (0.62) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL5349832 | 0.79 | KDM4E (0.62) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL24220248 | 0.79 | LMNA (0.62) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL780067 | 0.79 | KDM4E (0.62) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL5360459 | 0.78 | KDM4E (0.61) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL6137154 | 0.77 | KDM4E (0.65) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL11689296 | 0.77 | KDM4E (0.59) | KDM4ELMNATHRBALDH1A1EPHX2 | |
| SCHEMBL14822849 | 0.77 | KDM4E (0.59) | KDM4ELMNATHRBALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4039491-A | IMPACT STRENGTH, NORBORNENE DERIVATIVE CONTAINING POLAR GROUP | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1977-08-02 | — | — | US | claimed |
| EP-4617314-A1 | COMPOSITION FOR FORMING A MOLDED PRODUCT HAVING LOW DIELECTRIC LOSS, METHOD FOR FORMING A MOLDED PRODUCT, AND MOLDED PRODUCT HAVING LOW DIELECTRIC LOSS | Daikin Industries, Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-20200390777-A1 | LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF | SEAPORT THERAPEUTICS, INC. | 2020-12-17 | — | — | US | disclosed |
| EP-3669978-A1 | BI-FUNCTIONAL NANOHYBRIDS | Université de Bourgogne (FR) | 2020-06-24 | — | — | EP | disclosed |
| US-10329383-B2 | Cyanate resin blends and radomes including them | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) | 2019-06-25 | — | — | US | disclosed |
| US-20190112406-A1 | Resins and Radomes Including Them | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION | 2019-04-18 | — | — | US | disclosed |
| US-20180258223-A1 | CYANATE RESIN BLENDS AND RADOMES INCLUDING THEM | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION | 2018-09-13 | — | — | US | disclosed |
| WO-2018151800-A2 | RADOME FABRICATION USING CYCLIC OLEFIN RESIN IN LIQUID MOLDING | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) | 2018-08-23 | — | — | WO | disclosed |
| US-9914803-B2 | Cyanate resin blends and radomes including them | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) | 2018-03-13 | — | — | US | disclosed |
| EP-3013869-A1 | RESINS AND RADOMES INCLUDING THEM | Saint-gobain Performance Plastics Corporation (US) | 2016-05-04 | — | — | EP | disclosed |
| US-5053471-A | Methathesis ring opening polymerization of polar substituted norbornenes or octahydromethanonphthalenes; optics | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-10-01 | — | — | US | disclosed |
| EP-0409291-A2 | Thermoplastic resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-01-23 | — | — | EP | disclosed |
| US-4980421-A | Dicyclopentadienyltitanium compounds, lithium compounds and reducing agents containing aluminum, zinc or magnesium; efficiency | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-12-25 | — | — | US | disclosed |
| EP-0339986-A1 | Novel catalyst for hydrogenation of polymer and process for hydrogenating polymer with the catalyst | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1989-11-02 | — | — | EP | disclosed |
| EP-0317262-A2 | Transparent resin material | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1989-05-24 | — | — | EP | disclosed |
| US-4250063-A | COORDINATION CATALYST COMPRISING AN ORGANIC COMPLEX OF TUNGSTEN OR MOLYBDENUM, A TITANIUM TETRAHALIDE, AND AN N-HALO IMIDE, A SULFIDE, A SULFOXIDE, OR A PHOSPHINE; POLYALKENAMERS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-02-10 | — | — | US | disclosed |
| US-4176220-A | COORDINATION CATALYST | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1979-11-27 | — | — | US | disclosed |
| US-4106943-A | RING-OPENED POLYMER OR COPOLYMER OF NORBORNENE DERIVATIVE | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4068063-A | Catalyst composition for ring-opening polymerization of norbornene derivatives and process for polymerizing same | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1978-01-10 | — | — | US | disclosed |
| US-4039491-A | IMPACT STRENGTH, NORBORNENE DERIVATIVE CONTAINING POLAR GROUP | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390777-A1 | LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF | MALT1, CYP2B6, LIPA | KDM4E 1491/4885LMNA 4002/4885THRB 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.